Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.860
-0.020 (-0.69%)
Sep 3, 2025, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 1.07 billion as of September 3, 2025. Its market cap has increased by 77.87% in one year.
Market Cap
1.07B
Enterprise Value
1.60B
Revenue
627.22M
Ranking
n/a
PE Ratio
189.87
Stock Price
2.86
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 1.07B, an increase of 303.80%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 1.07B | -1.55% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | 861.69M | 15.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.90B |
| Pro Medicus | 30.80B |
| Cochlear | 19.46B |
| Sonic Healthcare | 11.74B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.84B |
| Mesoblast | 2.59B |